Chandra Bhagat Pharma Limited
CBPL
Rank in Stocks
#30677
Chandra Bhagat Pharma Ltd. specializes in the distribution and... Chandra Bhagat Pharma Ltd. specializes in the distribution and commercialization of a diverse array of pharmaceutical, critical care, and general healthcare solutions. Their extensive product lineup encompasses various pharmaceutical formulations, notably intravenous (IV) and intramuscular (IM) injectable medications, alongside select tablet forms, serving both national and international clientele. Furthermore, the company actively promotes and markets active pharmaceutical ingredients (APIs). Their offerings are designed to address a spectrum of conditions, including rheumatoid and osteo-arthritis, osteoporosis, carpal tunnel syndrome, tendonitis, rotator cuff tears, muscular dystrophy, myasthenia gravis, and lupus erythematosus, among other health issues. Established in 1944 by Chandravadan C. Bhagat, the company's main operations are based in Mumbai, India.
Share Price
$0.61577238
Last synced: 2026-11-09
Market Cap
$4.65M
Change (1 day)
4.19%
Change (1 year)
36.56%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Chandra Bhagat Pharma Limited (CBPL)
Category
Healthcare
Operating Margin for Chandra Bhagat Pharma Limited (CBPL)
Operating Margin as of November 2026 TTM: 16.94%
According to Chandra Bhagat Pharma Limited's latest financial reports, its current operating margin (TTM) is 16.94%. At the end of 2025 the company had an operating margin of -2.78%.
Operating Margin history for Chandra Bhagat Pharma Limited from 2017 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | 16.94% | -709.35% |
| 2025 | -2.78% | -155.27% |
| 2024 | 5.03% | 52.42% |
| 2023 | 3.30% | -42.51% |
| 2022 | 5.74% | 0.70% |
| 2021 | 5.70% | 64.74% |
| 2020 | 3.46% | -17.81% |
| 2019 | 4.21% | -7.06% |
| 2018 | 4.53% | 5.59% |
| 2017 | 4.29% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 1.62% | -99.90% |
US
|
|
| 1.30% | -99.92% |
US
|
|
| 1.03% | -99.94% |
US
|
|
| 0.91% | -99.95% |
US
|
|
| 9.21% | -99.46% |
AU
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about Chandra Bhagat Pharma Limited's operating margin
What is Chandra Bhagat Pharma Limited's operating margin?
Chandra Bhagat Pharma Limited's operating margin is 16.94%, as of Nov 2026.
What was Chandra Bhagat Pharma Limited's operating margin in 2025?
In 2025, Chandra Bhagat Pharma Limited's operating margin was -2.78%, compared with 5.03% in 2024.
How has Chandra Bhagat Pharma Limited's operating margin changed since 2020?
From 2020 to 2025, Chandra Bhagat Pharma Limited's operating margin was highest in 2022 (5.74%) and lowest in 2025 (-2.78%).
How does Chandra Bhagat Pharma Limited's operating margin compare with similar companies?
Chandra Bhagat Pharma Limited's operating margin (16.94%) is higher than that of all 5 similar companies listed above. The highest among them is Sigma Healthcare Limited, with 9.21%.